Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

Veterans with apnea-hypopnea index scores implying no sleep apnea or severe sleep apnea had higher all-cause mortality rates ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Slow Wave is a fitted mouth guard made from a 3D scan of your teeth. Wayne Wagner, the man behind this alternative option, was diagnosed with the condition 20 years ago and thought he could come up ...

URATEX Philippines, the country’s leading sleep solutions provider, has officially partnered with the Philippine Society of ...

ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...

The inking ceremony, held at Uratex Alabang with the theme “Partnering to Provide Quality Sleep for Filipinos,” marked the ...